23andMe to market first at-home genetic test for breast cancer risk

The FDA cleared mail-order DNA testing firm 23andMe to offer the first-ever at-home tests for cancer-associated BRCA gene mutations that were made famous by Angelina Jolie in 2013.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news